299 filings
Page 13 of 15
8-K
eh3xcyue
18 Mar 10
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
nu8wb7ymt
12 Mar 10
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
8-K
igve6sd7ck ksonrk
11 Mar 10
Oncothyreon Announces Termination of Arrangement Agreement
12:00am
8-K
3iw2fpiipoh
18 Feb 10
Oncothyreon Announces Sale of Oncothyreon Canada
12:00am
8-K
f2n5i4t0
7 Dec 09
Departure of Directors or Certain Officers
12:00am
8-K/A
fce6jnh xa70vwog
7 Dec 09
Departure of Directors or Certain Officers
12:00am
8-K
he6ne
12 Nov 09
Oncothyreon Reports Third Quarter 2009
12:00am
8-K
nypo gncp3vcth774
14 Oct 09
Other Events
12:00am
8-K
09lsnniu53kpu2 5kde
5 Oct 09
Oncothyreon Announces Appointment of
12:00am
8-K
i1d9j4b 1hj
13 Aug 09
Oncothyreon Reports Second Quarter 2009
12:00am
8-K
9d27h45zmed24i6
10 Aug 09
Oncothyreon Announces Closing of
12:00am
8-K
hrcaaqitiku5yu6vhd
5 Aug 09
Other Events
12:00am
8-K
1y46ffsj v5
4 Aug 09
Oncothyreon Appoints Diana Hausman As Vice President of Clinical Development
12:00am
8-K
mil9yif6fcgd43g 8emi
3 Aug 09
Oncothyreon announces presentation of long-term Stimuvax data at World Conference on Lung Cancer
12:00am
8-K
8jt vmmo11lat5
22 Jun 09
Oncothyreon Announces Initiation of Phase 3 Trial of Stimuvax In Breast Cancer
12:00am
8-K
bsqvgfr236g5m8sy3w4a
15 Jun 09
Oncothyreon Appoints Scott Peterson As Vice President of Research and Development
12:00am
8-K
yquq9fkg 1w
27 May 09
Oncothyreon Announces Closing of $11.1 Million Registered Direct Financing
12:00am
8-K
cd6 ojs5ohbkas
20 May 09
Entry into a Material Definitive Agreement
12:00am